ECU Libraries Catalog

Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.

Author/creator United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law
Format Electronic and Book
Publication Info Washington : U.S. Government Publishing Office, 2018.
Description1 online resource (iv, 51 pages)
Supplemental Content https://purl.fdlp.gov/GPO/gpo93483
Subject(s)
Variant title Antitrust concerns and the Food and Drug Administration approval process
General note"Serial no. 115-27."
General noteCRDP Program record.
Source of descriptionOnline resource; title from PDF title screens (govinfo web site, viewed on June 27, 2018).
Issued in other formPrint version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process
Issued in other formMicrofiche version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process
Genre/formLegislative hearings.
Genre/formRules.
Genre/formLegislative hearings.
Technical rpt numberSerial no. 115-27 (United States. Congress. House. Committee on the Judiciary)
GPO item number1020-C (online)
Govt. docs number Y 4.J 89/1:115-27

Available Items

Library Location Call Number Status Item Actions
Joyner Electronic Resources Access Content Online ✔ Available